Capula Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-63,100
Closed -$2.93M 703
2023
Q2
$2.93M Buy
+63,100
New +$2.18M 0.07% 123

Capula Management's DICE Position: Q3 2023 in Review

Capula Management sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 213,800 shares — an estimated $9.93M sold.

Capula Management first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $9.93M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Capula Management reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Capula Management sold 213,800 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $9.93M.
  • Capula Management first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Capula Management's DICE Therapeutics, Inc. Common Stock position peaked at $9.93M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Capula Management's 13F filing for Q3 2023, filed 3 Nov 2023.